Rigel Pharmaceuticals (RIGL) Capital Expenditures (QoQ) (2010 - 2023)
Rigel Pharmaceuticals (RIGL) Capital Expenditures (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 107.14% |
| Sep 30, 2023 | 1,500.00% |
| Jun 30, 2023 | 98.98% |
| Mar 31, 2023 | -110.43% |
| Dec 31, 2022 | 238.64% |
| Sep 30, 2022 | -1,783.33% |
| Jun 30, 2022 | -116.07% |
| Mar 31, 2022 | 144.98% |
| Dec 31, 2021 | -392.94% |
| Sep 30, 2021 | -64.88% |
| Jun 30, 2021 | 8,166.67% |
| Mar 31, 2021 | -100.53% |
| Dec 31, 2020 | 581.44% |
| Sep 30, 2020 | 125.69% |
| Jun 30, 2020 | -207.08% |
| Mar 31, 2020 | -59.40% |
| Dec 31, 2019 | 8,405.56% |
| Sep 30, 2019 | -12.50% |
| Jun 30, 2019 | -166.67% |
| Mar 31, 2019 | -108.70% |